{
  "attach_pages": "5",
  "attach_size": "652",
  "attach_type": "0",
  "attach_url": "https://pdf.dfcfw.com/pdf/H3_AP201911041370322077_1.pdf?1572893611000.pdf",
  "company_code": "80187812",
  "eitime": "2019-11-04 18:53:31",
  "extend": {},
  "info_code": "AP201911041370322077",
  "language": "1",
  "notice_date": "2019-11-04 00:00:00",
  "notice_title": "3Q19 results beat expectations;still less attractive than its H shares;maintain HOLD",
  "page_size": 1,
  "page_size_ch": 0,
  "page_size_cht": 0,
  "page_size_en": 0,
  "researcher": "Harry He,Wong Chi Man",
  "security": [
    {
      "market_uni": "1",
      "publish_relation": [
        {
          "originalCode": "1042",
          "publishName": "医药商业"
        }
      ],
      "short_name": "上海医药",
      "short_name_ch": "上海医药",
      "short_name_cht": "上海醫藥",
      "short_name_en": "SHANGHAI PHARMA",
      "stock": "601607"
    }
  ],
  "short_name": "上海医药",
  "source_sample_name": "中国银河国际证券"
}